Cancer and neoplasms
Infection
A randomised trial to assess the use of ciprofloxacin prophylaxis to prevent bacterial infection in children treated on the induction phase of the ALLTogether1 treatment protocol (CiproPAL)
CiproPAL is a randomised,open-label trial in paediatric patients (1-17 years inclusive) with de-novo Acute Lymphoblastic Leukaemia treated on the existing ALLTogether-1 study (EudraCT 2018-001795-38,REC ref 20/LO/0848,Sponsor: Karolinska University) in the UK.
The two main aims of the CiproPAL trial are:
1. To assess the efficacy of ciprofloxacin prophylaxis in reducing infections during the induction phase of the ALLTogether1 Trial.
2. To evaluate the impact of ciprofloxacin prophylaxis on antimicrobial resistance,both in terms of invasive infections and colonising organisms.
Patients will be randomised (1:1) ...
GO TO STUDY